Sheel Biotech (NSE:SHEEL) Total Receivables: ₹648 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SHEEL Sheel Biotech Ltd NSE:SHEEL
18 GF Score
Price ₹68.00
! 2 Warning Signs
View Full Analysis

What is Sheel Biotech Total Receivables?

Sheel Biotech NSE:SHEEL 18 Total Receivables is ₹648 Mil as of Mar. 2026. GuruFocus rates NSE:SHEEL with a GF Score™ of 18/100. The stock has 2 warning signs investors should review.

Sheel Biotech's Total Receivables for the quarter that ended in Mar. 2026 was ₹648 Mil.

Sheel Biotech Total Receivables Related Terms

Sheel Biotech Total Receivables Historical Data

* Premium members only.

The historical data trend for Sheel Biotech's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sheel Biotech Total Receivables Chart

Sheel Biotech Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Total Receivables
647.07 560.46 577.01 551.05 647.66

Sheel Biotech Semi-Annual Data
Mar22 Mar23 Mar24 Mar25 Mar26
Total Receivables 647.07 560.46 577.01 551.05 647.66
NSE:SHEEL
18GF Score
Sheel Biotech Ltd NSE:SHEEL
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sheel Biotech Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of ₹648 Mil mean?
Sheel Biotech (NSE:SHEEL) has a Total Receivables of ₹648 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Sheel Biotech and its competitors.
Is Sheel Biotech's Total Receivables too high?
Sheel Biotech's current Total Receivables is ₹648 Mil. Overall, Sheel Biotech has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sheel Biotech's Total Receivables compare to ADM and BG?
Sheel Biotech's Total Receivables of ₹648 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Consumer Packaged Goods company?
A good Total Receivables depends on the Consumer Packaged Goods industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Sheel Biotech and its competitors. Sheel Biotech's current Total Receivables is ₹648 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sheel Biotech stock overvalued right now?
Sheel Biotech (NSE:SHEEL) has a current Total Receivables of ₹648 Mil. The current Total Receivables is ₹648 Mil. Sheel Biotech's overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Sheel Biotech (NSE:SHEEL), the current Total Receivables is ₹648 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sheel Biotech Business Description

Address Guru Ravidas Marg, 8 Balaji Estates, 2nd Floor, Block-C, Kalkaji, South Delhi, New Delhi, IND, 110019
Sheel Biotech Ltd is engaged in the business of growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. It manufactures and maintain greenhouses, offer services to farmers and provide training through Farmer Producer Organizations (FPOs). The company also has a Research and Development lab with a capacity of production of 10 million* planting materials which is duly recognized by the Department of Biotechnology (DBT), Government of India.
18GF Score

Get the complete analysis for NSE:SHEEL

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹68.00
Price